Kast, R.E.; Marques Vieira, B.; Barros da Silva, E., Jr.
A New Adjuvant Treatment for Glioblastoma Using Aprepitant, Vortioxetine, Roflumilast and Olanzapine: The AVRO Regimen. Int. J. Mol. Sci. 2025, 26, 6158.
https://doi.org/10.3390/ijms26136158
AMA Style
Kast RE, Marques Vieira B, Barros da Silva E Jr.
A New Adjuvant Treatment for Glioblastoma Using Aprepitant, Vortioxetine, Roflumilast and Olanzapine: The AVRO Regimen. International Journal of Molecular Sciences. 2025; 26(13):6158.
https://doi.org/10.3390/ijms26136158
Chicago/Turabian Style
Kast, Richard E., Bruno Marques Vieira, and Erasmo Barros da Silva, Jr.
2025. "A New Adjuvant Treatment for Glioblastoma Using Aprepitant, Vortioxetine, Roflumilast and Olanzapine: The AVRO Regimen" International Journal of Molecular Sciences 26, no. 13: 6158.
https://doi.org/10.3390/ijms26136158
APA Style
Kast, R. E., Marques Vieira, B., & Barros da Silva, E., Jr.
(2025). A New Adjuvant Treatment for Glioblastoma Using Aprepitant, Vortioxetine, Roflumilast and Olanzapine: The AVRO Regimen. International Journal of Molecular Sciences, 26(13), 6158.
https://doi.org/10.3390/ijms26136158